Real-World Registry Data Identify Predictors of Biologic Switching in Psoriasis Care

A new analysis from the CorEvitas Psoriasis Registry highlights baseline clinical and patient-reported features associated with switching biologic therapies in real-world practice, offering insights to support earlier, shared decision-making.